Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Cholestasis, progressive familial intrahepatic 3
0.770 Biomarker disease BEFREE Here, we report results from treating two- or five-week-old Abcb4<sup>-/-</sup> mice with an AAV vector expressing human ABCB4, resulting in significant decreases of PFIC3 disease biomarkers. 31836711 2019
Cholestasis, progressive familial intrahepatic 3
0.770 GeneticVariation disease BEFREE Patients 2 and 3 were diagnosed with MDR3 deficiency due to recessive mutations in ABCB4. 31000363 2019
Cholestasis, progressive familial intrahepatic 3
0.770 Biomarker disease BEFREE In conclusion, the obtained results suggest that some synonymous SNPs in the ABCB4 gene, considered up to now as neutral, may be involved in the MDR3 deficiency. 30079523 2018
Cholestasis, progressive familial intrahepatic 3
0.770 Biomarker disease BEFREE Herein, we report a case of severe MDR3 deficiency in a male child diagnosed with negative MDR3 immunostaining in hepatic canaliculi who underwent LDLT at our centre. 28127842 2017
Cholestasis, progressive familial intrahepatic 3
0.770 GeneticVariation disease UNIPROT Functional defect of variants in the adenosine triphosphate-binding sites of ABCB4 and their rescue by the cystic fibrosis transmembrane conductance regulator potentiator, ivacaftor (VX-770). 28012258 2017
Cholestasis, progressive familial intrahepatic 3
0.770 Biomarker disease CTD_human 8-Methoxypsoralen disrupts MDR3-mediated phospholipids efflux and bile acid homeostasis and its relevance to hepatotoxicity. 28552422 2017
Cholestasis, progressive familial intrahepatic 3
0.770 Biomarker disease GENOMICS_ENGLAND Advantages and pitfalls of an extended gene panel for investigating complex neurometabolic phenotypes. 27604308 2016
Cholestasis, progressive familial intrahepatic 3
0.770 GeneticVariation disease BEFREE In silico investigation of the impact of synonymous variants in ABCB4 gene on mRNA stability/structure, splicing accuracy and codon usage: Potential contribution to PFIC3 disease. 27788395 2016
Cholestasis, progressive familial intrahepatic 3
0.770 Biomarker disease BEFREE Herein, we report the clinical and histopathologic features of 10 cases (6 male/4 female) in infants and children with severe MDR3 deficiency (age range of 8 months to 7 years) diagnosed with negative MDR3 immunostaining in hepatic canaliculi. 26117383 2015
Cholestasis, progressive familial intrahepatic 3
0.770 GeneticVariation disease UNIPROT Functional analysis of ABCB4 mutations relates clinical outcomes of progressive familial intrahepatic cholestasis type 3 to the degree of MDR3 floppase activity. 24594635 2015
Cholestasis, progressive familial intrahepatic 3
0.770 GeneticVariation disease UNIPROT Two ABCB4 point mutations of strategic NBD-motifs do not prevent protein targeting to the plasma membrane but promote MDR3 dysfunction. 24045840 2014
Cholestasis, progressive familial intrahepatic 3
0.770 GeneticVariation disease UNIPROT Molecular mechanistic explanation for the spectrum of cholestatic disease caused by the S320F variant of ABCB4. 24806754 2014
Cholestasis, progressive familial intrahepatic 3
0.770 Biomarker disease CTD_human Effects of cellular, chemical, and pharmacological chaperones on the rescue of a trafficking-defective mutant of the ATP-binding cassette transporter proteins ABCB1/ABCB4. 22184139 2012
Cholestasis, progressive familial intrahepatic 3
0.770 GeneticVariation disease UNIPROT Clinical features and genotype-phenotype correlations in children with progressive familial intrahepatic cholestasis type 3 related to ABCB4 mutations. 21119540 2011
Cholestasis, progressive familial intrahepatic 3
0.770 GermlineCausalMutation disease ORPHANET Clinical features and genotype-phenotype correlations in children with progressive familial intrahepatic cholestasis type 3 related to ABCB4 mutations. 21119540 2011
Cholestasis, progressive familial intrahepatic 3
0.770 GeneticVariation disease UNIPROT We report the molecular characterization of 68 PFIC3 index cases enrolled in a multicenter study, which represents the largest cohort of PFIC3 patients screened for ABCB4 mutations to date. 17726488 2007
Cholestasis, progressive familial intrahepatic 3
0.770 GermlineCausalMutation disease ORPHANET We report the molecular characterization of 68 PFIC3 index cases enrolled in a multicenter study, which represents the largest cohort of PFIC3 patients screened for ABCB4 mutations to date. 17726488 2007
Cholestasis, progressive familial intrahepatic 3
0.770 GeneticVariation disease BEFREE We report the molecular characterization of 68 PFIC3 index cases enrolled in a multicenter study, which represents the largest cohort of PFIC3 patients screened for ABCB4 mutations to date. 17726488 2007
Cholestasis, progressive familial intrahepatic 3
0.770 GeneticVariation disease UNIPROT Although biliary cirrhosis associated with MDR3 deficiency typically appears before the age of 25 years, in our case, the relatively mild MDR3 dysfunction allowed for a slower progression of the disease with established, well-advanced cirrhosis in the fifth decade of life. 12671900 2003
Cholestasis, progressive familial intrahepatic 3
0.770 GeneticVariation disease UNIPROT The wide spectrum of multidrug resistance 3 deficiency: from neonatal cholestasis to cirrhosis of adulthood. 11313315 2001
Cholestasis, progressive familial intrahepatic 3
0.770 GeneticVariation disease UNIPROT Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis. 9419367 1998
Cholestasis, progressive familial intrahepatic 3
0.770 CausalMutation disease CLINVAR